Fabtech Technologies Secures ₹31.23 Crore Contract for Veterinary Vaccine Facility in Botswana

Fabtech Technologies Secures ₹31.23 Crore Contract for Veterinary Vaccine Facility in Botswana​

Fabtech Technologies Limited (FTL), recognized as a global leader in pharmaceutical and life sciences infrastructure, has secured a significant contract valued at ₹31.23 crore. The project involves providing critical internal infrastructure scope for a new Veterinary Vaccine Manufacturing Facility located in Botswana. This contract solidifies Fabtech's expanding footprint across Africa’s healthcare, biotechnology, and vaccine manufacturing sectors.

The facility is poised to make a substantial contribution toward enhancing Southern Africa's veterinary vaccine production capacity. By supporting regional initiatives focused on animal health, food security, and disease prevention, the project marks a key advancement in promoting local vaccine production across the continent. This development is seen as a major step toward bolstering regional healthcare resilience while reducing reliance on imports of vaccines.

Under the scope of work for this project, Fabtech will be supplying an integrated infrastructure platform designed for safe, efficient, and scalable vaccine production. This includes advanced GMP-compliant internal infrastructure, precision HVAC systems, clean utilities, and critical MEP services, all engineered to meet stringent international manufacturing standards.

The commissioning of this facility extends beyond veterinary healthcare. The contract strengthens Fabtech’s strategic position within Africa's growing ecosystem for vaccines and biologics manufacturing. The deployed infrastructure establishes a crucial foundation for future capabilities in sterile injectable manufacturing, biological products, and critical vaccines across the African continent, supporting the region's ambition for vaccine self-sufficiency in the long term.

This milestone reinforces Fabtech’s vision as a leading Life Sciences Infrastructure Platform, enabling world-class pharmaceutical, biotechnology, and vaccine manufacturing within emerging markets.

FABTECH Stock Price Movement​

Shares of Fabtech Technologies Limited on Monday slipped by 0.32% to settle at ₹145.96, shedding ₹0.47 in the session. The stock recorded a traded volume of 155,367 shares during the close.